Skip to content
Search

Latest Stories

Submit Guest Post

Only one in five with Covid symptoms in UK seek test, says study

ONLY one person in five in Britain with Covid-19 symptoms has sought or would get a test done, a study has found.

This is likely to happen for people on low pay and poor adherence to the government's rules.


This was a study done by the British Medical Journal, where 18 per cent said they got or would get a test done after showing symptoms and 42.5 per cent would fully adhere to isolation rules.

"This is such an important part of any government's pandemic control measures," one of the authors of the report - Susan Michie, a University College London health psychology professor - told BBC Radio.

"I think given that new cases a day are stuck at around 4,000 this is a ... real area where we could begin to make progress."

Michie said people told researchers they did not isolate because they needed to leave home for provisions or caring responsibilities or to go to work, often in low-paid jobs.

She said developing countries such as Vietnam were doing a good job at providing financial support to help people follow isolation rules.

However, Britain has earmarked £37 billion for spending on its test and trace system over two years. Lawmakers said last month that it had failed in its key goals.

The survey was based on responses from 53,880 people - some of whom had contracted Covid-19 - between March 2 last year and January 27 2021.

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

Weekly insulin jab

A weekly insulin jab could reduce the burden of daily injections for some people with type 2 diabetes

iStock

From 365 injections to 52: New weekly insulin jab could make life easier for patients

  • The treatment could reduce insulin injections from 365 a year to just 52.
  • NICE has recommended the weekly treatment, but it still needs MHRA approval.
  • People who rely on carers or struggle with daily injections could benefit most.

For some people with type 2 diabetes, managing their condition could soon involve one insulin injection a week instead of one every day.

The National Institute for Health and Care Excellence (NICE) has recommended insulin efsitora alfa, also known as Onswik and made by Eli Lilly, in its final draft guidance. If approved by the medicines regulator and subsequently rolled out on the NHS, the treatment could reduce the number of annual insulin injections from 365 to 52.

Keep ReadingShow less